These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9486935)

  • 1. Angiotensin-converting enzyme gene insertion/deletion polymorphism and left ventricular hypertrophy in hemodialysis patients.
    Nagahara T; Ishigami T; Sano T; Ikeda Y; Hibi K; Uneda S; Umemura S; Ishii M
    Jpn Heart J; 1997 Nov; 38(6):821-30. PubMed ID: 9486935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No association between deletion-type angiotensin-converting enzyme gene polymorphism and left-ventricular hypertrophy in hemodialysis patients.
    Yildiz A; Akkaya V; Hatemi AC; Cine N; Tükek T; Görçin B; Demirel S; Türk S; Sever MS
    Nephron; 2000 Feb; 84(2):130-5. PubMed ID: 10657713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progression of left ventricular hypertrophy and the angiotensin-converting enzyme gene polymorphism in hypertrophic cardiomyopathy.
    Doolan G; Nguyen L; Chung J; Ingles J; Semsarian C
    Int J Cardiol; 2004 Aug; 96(2):157-63. PubMed ID: 15314809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The deletion polymorphism of the angiotensin I-converting enzyme gene is associated with target organ damage in essential hypertension.
    Pontremoli R; Sofia A; Tirotta A; Ravera M; Nicolella C; Viazzi F; Bezante GP; Borgia L; Bobola N; Ravazzolo R; Sacchi G; Deferrari G
    J Am Soc Nephrol; 1996 Dec; 7(12):2550-8. PubMed ID: 8989733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between angiotensin-converting enzyme gene polymorphisms and regression of left ventricular hypertrophy in patients treated with angiotensin-converting enzyme inhibitors.
    Kohno M; Yokokawa K; Minami M; Kano H; Yasunari K; Hanehira T; Yoshikawa J
    Am J Med; 1999 May; 106(5):544-9. PubMed ID: 10335726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of association between ACE gene polymorphism and left ventricular hypertrophy in essential hypertension.
    Gomez-Angelats E; de la Sierra A; Enjuto M; Sierra C; Oriola J; Francino A; Paré JC; Poch E; Coca A
    J Hum Hypertens; 2000 Jan; 14(1):47-9. PubMed ID: 10673731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insertion/deletion polymorphism in intron 16 of the ACE gene and left ventricular hypertrophy in patients with end-stage renal disease.
    Osono E; Kurihara S; Hayama N; Sakurai Y; Ohwada K; Onoda N; Takeuchi M; Tomizawa T; Komaba Y; Hashimoto K; Matsunobu S; Yoneshima H; Iino Y
    Am J Kidney Dis; 1998 Nov; 32(5):725-30. PubMed ID: 9820440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin-converting enzyme gene polymorphism, left ventricular remodeling, and exercise capacity in strength-trained athletes.
    Kasikcioglu E; Kayserilioglu A; Ciloglu F; Akhan H; Oflaz H; Yildiz S; Peker I
    Heart Vessels; 2004 Nov; 19(6):287-93. PubMed ID: 15799176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin-converting enzyme gene polymorphism influences degree of left ventricular hypertrophy and its regression in patients undergoing operation for aortic stenosis.
    Dellgren G; Eriksson MJ; Blange I; Brodin LA; Rådegran K; Sylvén C
    Am J Cardiol; 1999 Oct; 84(8):909-13. PubMed ID: 10532509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletion polymorphism of angiotensin-converting enzyme gene and left ventricular hypertrophy in southern Italian patients.
    Perticone F; Ceravolo R; Cosco C; Trapasso M; Zingone A; Malatesta P; Perrotti N; Tramontano D; Mattioli PL
    J Am Coll Cardiol; 1997 Feb; 29(2):365-9. PubMed ID: 9014990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletion polymorphism of the angiotensin-converting enzyme gene is independently associated with left ventricular mass and geometric remodeling in systemic hypertension.
    Gharavi AG; Lipkowitz MS; Diamond JA; Jhang JS; Phillips RA
    Am J Cardiol; 1996 Jun; 77(15):1315-9. PubMed ID: 8677872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [I/D gene polymorphism of the angiotensin-converting enzyme and left ventricular hypertrophy. Response to converting enzyme inhibitors].
    Rugale C; du Cailar G; Ribstein J; Mimran A
    Arch Mal Coeur Vaiss; 2003; 96(7-8):772-5. PubMed ID: 12945221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of the relationships between angiotensin- converting enzyme gene, chymase gene polymorphisms, pharmacological treatment with ACE inhibitor and regression of left ventricular hypertrophy in essential hypertension patients treated with benazepril.
    He H; Li LM; Cao WH; Sun NL; Liu MZ; Hu YH
    Ann Hum Biol; 2005; 32(1):30-43. PubMed ID: 15788353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Association between angiotensin converting enzyme gene, chymase gene and regression of left ventricular hypertrophy in patients treated with angiotensin converting enzyme inhibitors].
    He H; Li LM; Cao WH; Liu MZ; Sun NL; Lü J; Hu YH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Sep; 25(9):756-60. PubMed ID: 15555355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of a deletion polymorphism of the angiotensin-converting enzyme gene with left-ventricular hypertrophy in Japanese women with essential hypertension; multicenter study of 1,919 subjects.
    Kimura M; Yokota M; Fujimura T; Kato S; Hirayama H; Tsunekawa A; Maeda M; Inagaki H; Ogawa S; Nakashima N; Yamada Y
    Cardiology; 1997; 88(4):309-14. PubMed ID: 9197423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of left ventricular mass changes after renal transplantation by polymorphism of the angiotensin-converting-enzyme gene.
    Hernández D; Lacalzada J; Rufino M; Torres A; Martín N; Barragán A; Barrios Y; Macía M; de Bonis E; Lorenzo V; Rodríguez A; González-Posada JM; Salido E
    Kidney Int; 1997 Apr; 51(4):1205-11. PubMed ID: 9083287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regression of left ventricular hypertrophy by lisinopril after renal transplantation: role of ACE gene polymorphism.
    Hernández D; Lacalzada J; Salido E; Linares J; Barragán A; Lorenzo V; Higueras L; Martín B; Rodríguez A; Laynez I; González-Posada JM; Torres A
    Kidney Int; 2000 Aug; 58(2):889-97. PubMed ID: 10916115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [ACE gene polymorphism correlation (I/D) with the ventricular function in patients with ischemic and idiopathic dilated cardiomyopathy].
    Avila-Vanzzini N; Espínola-Zavaleta N; Masso-Rojas F; Varela-López E; Casanova-Garcés JM; Kury-Alfaro J; Herrera-Bello H
    Rev Invest Clin; 2006; 58(1):39-46. PubMed ID: 16789598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left ventricular hypertrophy and angiotensin-converting enzyme gene polymorphism in renal allograft recipients.
    Koç M; Ozener IC; Tezcan H; Bihorac A; Isbir T; Akoğlu E
    Transplant Proc; 2000 May; 32(3):542-4. PubMed ID: 10812105
    [No Abstract]   [Full Text] [Related]  

  • 20. QT dispersion and left ventricular hypertrophy in athletes: relationship with angiotensin-converting enzyme I/D polymorphism.
    Tanriverdi H; Kaftan HA; Evrengul H; Dursunoglu D; Turgut G; Kiliç M
    Acta Cardiol; 2005 Aug; 60(4):387-93. PubMed ID: 16128371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.